Om

COSCIENS Biopharma Inc. is a specialty biopharmaceutical and life science company headquartered in Toronto, Canada. The firm focuses on developing and commercializing pharmaceutical therapeutics, diagnostic tests, and natural active ingredients for healthcare and personal care markets. It operates through two main business segments: the Active Ingredient segment, which uses proprietary extraction and manufacturing technologies to produce plant-based ingredients such as avenanthramides and beta glucan for cosmeceutical and skincare applications; and the Biopharmaceutical/Pharmaceutical segment, which centers on prescription therapeutics and diagnostic products. A key asset in its portfolio is Macimorelin (marketed as Macrilen and Ghryvelin), an orally administered diagnostic test for adult growth hormone deficiency that holds regulatory approvals in major jurisdictions. COSCIENS Biopharma serves markets in North America, Europe, and other international regions, addressing needs in endocrinology, biotechnology, medical research, and advanced skincare through its diversified mix of active ingredients and biopharmaceutical solutions.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I COSCIENS BIOPHARMA MED ENDAVU: Køb COSCIENS Biopharma ($CSCI) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i COSCIENS Biopharma, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.